Home › Stomach Cancer › Indiana › Fort Wayne
Stomach Cancer clinical trials in Fort Wayne, IN
3 studies for Stomach Cancer are looking for participants at sites in and around Fort Wayne (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecruitingPhase 1
- Fort Wayne Medical Oncology and Hematology, Inc, Fort Wayne
Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
- Parkview Research Center, Fort Wayne
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
RecruitingPhase 1
- Fort Wayne Medical Oncology and Hematology, Inc /ID# 232593, Fort Wayne
About Stomach Cancer
Did you know risk factors for stomach (gastric) cancer include a diet high in salty or smoked food or having an H. pylori infection? Learn more here.
More about Stomach Cancer on MedlinePlus
Stomach Cancer trials in other cities
- Houston, TX42 studies
- Boston, MA32 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Baldwin Park, CA22 studies
- Los Angeles, CA22 studies
- Arlington, VA20 studies
- Dallas, TX19 studies
- San Antonio, TX19 studies
- St. Louis, MO18 studies
- Grand Rapids, MI18 studies
- Chicago, IL16 studies
Other studies in Fort Wayne
- Non-Small Cell Lung Cancer17 studies
- Ovarian Cancer8 studies
- Cancer (all types)7 studies
- Chronic Lymphocytic Leukemia7 studies
- Breast Cancer7 studies
- Lung Cancer6 studies
- Metastatic Cancer6 studies
- Endometrial Cancer5 studies
- Melanoma4 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Triple-Negative Breast Cancer4 studies
- Colorectal Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.